ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities

41Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors with established roles in stem cell self-renewal, lineage commitment, and niche interactions. While deregulated expression of ID proteins in cancer was identified more than a decade ago, emerging evidence has revealed a central role for ID proteins in neoplastic progression of multiple tumor types that often mirrors their function in physiological stem and progenitor cells. ID proteins are required for the maintenance of cancer stem cells, self-renewal, and proliferation in a range of malignancies. Furthermore, ID proteins promote metastatic dissemination through their role in remodeling the tumor microenvironment and by promoting tumor-associated endothelial progenitor cell proliferation and mobilization. Here, we discuss the latest findings in this area and the clinical opportunities that they provide. © The American Society of Gene & Cell Therapy.

Cite

CITATION STYLE

APA

Nair, R., Teo, W. S., Mittal, V., & Swarbrick, A. (2014). ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. Molecular Therapy. Nature Publishing Group. https://doi.org/10.1038/mt.2014.83

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free